Cargando…
The potential diagnosis role of TP53 mutation in advanced bladder cancer: A meta‐analysis
BACKGROUND: Bladder cancer is one of the most common urological cancers all over the world, and NMIBC occupies almost 80% of recently diagnosed bladder cancer cases. Progress and recurrence of bladder cancer are the main problems during the disease. The level of TP53 mutation is obviously higher in...
Autores principales: | Liao, Yihao, Tang, Huiqin, Wang, Miaomiao, Wang, Keke, Wang, Youzhi, Jiang, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128305/ https://www.ncbi.nlm.nih.gov/pubmed/33780049 http://dx.doi.org/10.1002/jcla.23765 |
Ejemplares similares
-
Comprehensive analysis of Transcription Factors identified novel prognostic biomarker in human bladder cancer
por: Liao, Yihao, et al.
Publicado: (2021) -
The role of distinct co-mutation patterns with TP53 mutation in immunotherapy for NSCLC
por: Wang, Shuhang, et al.
Publicado: (2020) -
BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway
por: Jiang, Ning, et al.
Publicado: (2021) -
Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
por: Li, Xuerui, et al.
Publicado: (2020) -
Significance of TP53 mutation in bladder cancer disease progression and drug selection
por: Wu, Guang, et al.
Publicado: (2019)